Mia D. Champion, PhD - Publications

Affiliations: 
Mayo Clinic, Rochester, MN, United States 
Area:
Bioinformatics Scientist
Website:
http://www.researchgate.net/profile/Mia_Champion

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, et al. Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25. PMID 28003660 DOI: 10.1038/S41598-016-0021-4  1
2015 Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, et al. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. Plos One. 10: e0132831. PMID 26181416 DOI: 10.1371/Journal.Pone.0132831  1
2015 Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, et al. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. PMID 26073078 DOI: 10.1038/onc.2015.221  1
2015 Yamada D, Rizvi S, Razumilava N, Bronk SF, Davila JI, Champion MD, Borad MJ, Bezerra JA, Chen X, Gores GJ. IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism. Hepatology (Baltimore, Md.). 61: 1627-42. PMID 25580681 DOI: 10.1002/hep.27687  1
2015 Zhu YX, Yin H, Bruins LA, Shi CX, Jedlowski P, Aziz M, Sereduk C, Kortuem KM, Schmidt JE, Champion M, Braggio E, Keith Stewart A. RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125: 483-91. PMID 25395420 DOI: 10.1182/blood-2014-05-577130  1
2015 Kortüm KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, et al. Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. British Journal of Haematology. 168: 507-10. PMID 25302557 DOI: 10.1111/bjh.13171  1
2015 Francis P, Alvarez LM, Lenkiewicz E, Champion M, Evers L, Anderson KL, McCullough AE, Barrett MT, Pockaj B. Abstract P2-03-07: Deep clonal profiling identifies distinct mechanisms of heterogeneity and evolution in breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-03-07  1
2015 Andreozzi M, Francis P, Lenkiewicz E, Champion M, Laughlin B, Anderson K, Cunliffe H, McCullough AE, Barrett MT, Pockaj B. Abstract LB-175: Deep clonal profiling identifies distinct mechanisms of heterogeneity and evolution in breast cancer Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2015-Lb-175  1
2015 Champion MD, Francis P, Pockaj BA, Barrett MT. Abstract 4861: Hybrid clustering methodologies to distinguish CNAs and/or SNVs that drive subclonal differentiation in samples from a breast cancer patient primary tumor and metastatic lymph nodes Cancer Research. 75: 4861-4861. DOI: 10.1158/1538-7445.Am2015-4861  1
2015 Champion MD, Hlady RA, Yan H, Evans J, Nie J, Lee JH, Bogenberger J, Nandakumar K, Davila J, Moore R, Nair A, O'Brien D, Zhu YX, Kortum KM, Ordog T, et al. Bioinformatics strategies for identifying regions of epigenetic deregulation associated with aberrant transcript splicing and RNA-editing Bioinformatics 2015 - 6th International Conference On Bioinformatics Models, Methods and Algorithms, Proceedings; Part of 8th International Joint Conference On Biomedical Engineering Systems and Technologies, Biostec 2015. 163-170.  1
2014 Zhu YX, Braggio E, Shi CX, Kortuem KM, Bruins LA, Schmidt JE, Chang XB, Langlais P, Luo M, Jedlowski P, LaPlant B, Laumann K, Fonseca R, Bergsagel PL, Mikhael J, ... ... Champion MD, et al. Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood. 124: 536-45. PMID 24914135 DOI: 10.1182/blood-2014-02-557819  1
2014 Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, Condjella RM, Block M, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135. PMID 24550739 DOI: 10.1371/Journal.Pgen.1004135  1
2014 Egan JB, Barrett MT, Champion MD, Middha S, Lenkiewicz E, Evers L, Francis P, Schmidt J, Shi CX, Van Wier S, Badar S, Ahmann G, Kortuem KM, Boczek NJ, Fonseca R, et al. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. Plos One. 9: e87113. PMID 24505276 DOI: 10.1371/Journal.Pone.0087113  1
2014 Schuster SR, Kortuem KM, Zhu YX, Braggio E, Shi CX, Bruins LA, Schmidt JE, Ahmann G, Kumar S, Rajkumar SV, Mikhael J, Laplant B, Champion MD, Laumann K, Barlogie B, et al. The clinical significance of cereblon expression in multiple myeloma. Leukemia Research. 38: 23-8. PMID 24129344 DOI: 10.1016/J.Leukres.2013.08.015  1
2014 Zhu YX, Braggio E, Shi C, Kortüm KM, Bruins LA, Schmidt JE, Chang X, Langlais P, Moulun L, Jedlowski P, LaPlant B, Laumann KM, Fonseca R, Bergsagel PL, Mikhael J, ... ... Champion MD, et al. Ikaros expression levels to predict response and survival following pomalidomide and dexamethasone in multiple myeloma (MM). Journal of Clinical Oncology. 32: 8540-8540. DOI: 10.1200/Jco.2014.32.15_Suppl.8540  1
2014 Champion MD, Yan H, Evans J, Nie J, Lee J, Davila JI, Moore R, Ordog T, Zhang Z, Joseph RW, Stewart AK, Kocher JA, Jonasch E, Ho TH. A tool to predict post-transcriptional instability related to the dysregulation of the SETD2 histone methyltransferase in renal cell carcinoma (RCC). Journal of Clinical Oncology. 32: 11072-11072. DOI: 10.1200/Jco.2014.32.15_Suppl.11072  1
2014 Kortuem KM, Stewart AK, Bruins LA, Ahmann G, Vasmatzis G, Rajkumar SV, Kumar S, Dispenzieri A, Lacy MQ, Gertz MA, Fonseca R, Champion M, Bergsagel PL, Braggio E. Development and Results of a Multiple Myeloma Specific Custom 77-Gene Mutation Panel for Clinical Targeted Sequencing Blood. 124: 169-169. DOI: 10.1182/Blood.V124.21.169.169  1
2014 Egan JB, Bryce AH, Champion MD, Liang WS, Fonseca R, McCullough AE, Barrett MT, Hunt K, Condjella RM, McWilliams RR, Mastrian SD, LoBello J, Hoff DV, Craig DW, Stewart AK, et al. Abstract 4694: Indices of actionability and clinical utility in a CLIA-enabled study of whole genome/exome/RNA sequencing in 33 cancer patients: Actionable vs. utility Cancer Research. 74: 4694-4694. DOI: 10.1158/1538-7445.Am2014-4694  1
2013 Pearson T, Hornstra HM, Sahl JW, Schaack S, Schupp JM, Beckstrom-Sternberg SM, O'Neill MW, Priestley RA, Champion MD, Beckstrom-Sternberg JS, Kersh GJ, Samuel JE, Massung RF, Keim P. When outgroups fail; phylogenomics of rooting the emerging pathogen, Coxiella burnetii. Systematic Biology. 62: 752-62. PMID 23736103 DOI: 10.1093/Sysbio/Syt038  1
2013 Champion MD, Gray V, Eberhard C, Kumar S. The evolutionary history of amino acid variations mediating increased resistance of S. aureus identifies reversion mutations in metabolic regulators. Plos One. 8: e56466. PMID 23424663 DOI: 10.1371/journal.pone.0056466  1
2013 Zhu YX, Bruins L, Shi C, Schmidt J, Sereduk C, Champion M, Braggio E, Yin H, Stewart AK. A Synthetic Lethality Druggable Genome RNAi Screen Identifies Genes Mediating Sensitivity To Lenalidomide In Multiple Myeloma Including RSK2 Blood. 122: 3084-3084. DOI: 10.1182/Blood.V122.21.3084.3084  1
2013 Borad MJ, Egan J, Champion M, Hunt K, McWilliams R, McCullough A, Aldrich J, Nasser S, Liang W, Barrett M, Craig D, Ramanathan R, Carpten J, Stewart AK, Bryce A. Abstract CT112: Implementation of CLIA enabled integrated whole genome (WGS)/exome (WES)/transcriptome (RNAseq) next-gen sequencing to identify therapeutically relevant targets in advanced cancer patients Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C66  1
2011 Desjardins CA, Champion MD, Holder JW, Muszewska A, Goldberg J, Bailão AM, Brigido MM, Ferreira ME, Garcia AM, Grynberg M, Gujja S, Heiman DI, Henn MR, Kodira CD, León-Narváez H, et al. Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis. Plos Genetics. 7: e1002345. PMID 22046142 DOI: 10.1371/Journal.Pgen.1002345  1
2011 Chanturia G, Birdsell DN, Kekelidze M, Zhgenti E, Babuadze G, Tsertsvadze N, Tsanava S, Imnadze P, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Champion MD, Sinari S, Gyuranecz M, Farlow J, Pettus AH, et al. Phylogeography of Francisella tularensis subspecies holarctica from the country of Georgia. Bmc Microbiology. 11: 139. PMID 21682874 DOI: 10.1186/1471-2180-11-139  1
2011 Champion MD. Host-pathogen o-methyltransferase similarity and its specific presence in highly virulent strains of Francisella tularensis suggests molecular mimicry. Plos One. 6: e20295. PMID 21637805 DOI: 10.1371/journal.pone.0020295  1
2009 Champion MD, Zeng Q, Nix EB, Nano FE, Keim P, Kodira CD, Borowsky M, Young S, Koehrsen M, Engels R, Pearson M, Howarth C, Larson L, White J, Alvarado L, et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. Plos Pathogens. 5: e1000459. PMID 19478886 DOI: 10.1371/Journal.Ppat.1000459  1
2005 Champion M. Spiraled origins. Molecular Cell. 17: 475-7. PMID 15721251 DOI: 10.1016/j.molcel.2005.02.006  1
2004 Champion M. Gag order. Molecular Cell. 14: 694-6. PMID 15200947 DOI: 10.1016/j.molcel.2004.06.014  1
2003 Harris D, Orme C, Kramer J, Namba L, Champion M, Palladino MJ, Natzle J, Hawley RS. A deficiency screen of the major autosomes identifies a gene (matrimony) that is haplo-insufficient for achiasmate segregation in Drosophila oocytes. Genetics. 165: 637-52. PMID 14573476  1
2002 Champion MD, Hawley RS. Playing for half the deck: the molecular biology of meiosis. Nature Cell Biology. 4: s50-6. PMID 12479615 DOI: 10.1038/ncb-nm-fertilityS50  1
Show low-probability matches.